These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19917318)

  • 1. Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.
    Wallis CL; Papathanasopoulos MA; Lakhi S; Karita E; Kamali A; Kaleebu P; Sanders E; Anzala O; Bekker LG; Stevens G; de Wit TF; Stevens W
    J Virol Methods; 2010 Feb; 163(2):505-8. PubMed ID: 19917318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
    Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
    J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.
    Inzaule S; Yang C; Kasembeli A; Nafisa L; Okonji J; Oyaro B; Lando R; Mills LA; Laserson K; Thomas T; Nkengasong J; Zeh C
    J Clin Microbiol; 2013 Feb; 51(2):529-39. PubMed ID: 23224100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.
    Ziemniak C; Mengistu Y; Ruff A; Chen YH; Khaki L; Bedri A; Simen BB; Palumbo P; Eshleman SH; Persaud D
    J Clin Microbiol; 2011 Dec; 49(12):4077-82. PubMed ID: 21956987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients.
    Acharya A; Vaniawala S; Shah P; Misra RN; Wani M; Mukhopadhyaya PN
    PLoS One; 2014; 9(8):e105790. PubMed ID: 25157501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region only.
    Aitken SC; Bronze M; Wallis CL; Stuyver L; Steegen K; Balinda S; Kityo C; Stevens W; Rinke de Wit TF; Schuurman R
    J Clin Microbiol; 2013 Jun; 51(6):1757-61. PubMed ID: 23536405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System.
    Johannessen A; Garrido C; Zahonero N; Naman E; de Mendoza C
    J Antimicrob Chemother; 2011 Feb; 66(2):260-4. PubMed ID: 21115444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
    Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
    J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.
    Saravanan S; Vidya M; Balakrishnan P; Kumarasamy N; Solomon SS; Solomon S; Kantor R; Katzenstein D; Ramratnam B; Mayer KH
    J Virol Methods; 2009 Aug; 159(2):211-6. PubMed ID: 19490976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CODEHOP-Mediated PCR Improves HIV-1 Genotyping and Detection of Variants by MinION Sequencing.
    Sarkhouh H; Chehadeh W
    Microbiol Spectr; 2021 Oct; 9(2):e0143221. PubMed ID: 34668751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
    Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
    Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
    Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
    J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.
    Chaturbhuj DN; Nirmalkar AP; Paranjape RS; Tripathy SP
    PLoS One; 2014; 9(2):e87441. PubMed ID: 24533056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An affordable HIV-1 drug resistance monitoring method for resource limited settings.
    Manasa J; Danaviah S; Pillay S; Padayachee P; Mthiyane H; Mkhize C; Lessells RJ; Seebregts C; de Wit TF; Viljoen J; Katzenstein D; De Oliveira T
    J Vis Exp; 2014 Mar; (85):. PubMed ID: 24747156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C.
    Youngpairoj AS; Masciotra S; Garrido C; Zahonero N; de Mendoza C; García-Lerma JG
    J Antimicrob Chemother; 2008 Jun; 61(6):1217-20. PubMed ID: 18344550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.